Clinical Trials Browser

Phase 1/2 × regorafenib × Tumor-Agnostic × Clear all

NCT03722108 2023-10-16

REGIRI

Phase 1/2 Terminated

Adenocarcinoma

NCT01896856 2020-10-06

Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer

Phase 1/2 Completed

118 enrolled 16 charts

Neoplasm Metastasis